1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cardiovascular conditions
  5. Acute coronary syndromes

Guidance on the use of drugs for early thrombolysis in the treatment of acute myocardial infarction

Technology appraisal guidance [TA52] Published date: 30 October 2002

  • Guidance
  • Tools and resources
  • Information for the public
  • History
  • Overview
  • 1 Guidance
  • 2 Clinical need and practice
  • 3 The technology
  • 4 Evidence
  • 5 Proposed recommendations for further research
  • 6 Resource impact for the NHS
  • 7 Implementation and audit
  • 8 Related guidance
  • 9 Review of guidance
  • Appendix A. Appraisal Committee members
  • Appendix B. Sources of evidence considered by the Committee
  • Appendix C. Information for patients. Drugs for early thrombolysis in the treatment of acute myocardial infarction
  • Changes after publication
  • About this guidance
  • Share
    • Share
    • Linked In
    • Twitter
    • Facebook
    • Email
    • More...
  • Download

Guidance

  • Next

5 Proposed recommendations for further research

5 Proposed recommendations for further research

5.1 In light of the on-going introduction of pre-hospital thrombolysis, it is recommended that opportunities for the evaluation of the administration of thrombolytic drugs in pre-hospital settings are explored.


  • Next